Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,040 | 878 | 92.6% |
| Travel and Lodging | $917.89 | 2 | 5.3% |
| Education | $359.95 | 18 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,700 | 220 | $0 (2024) |
| Janssen Biotech, Inc. | $1,981 | 96 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,736 | 135 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,261 | 75 | $0 (2024) |
| Covidien LP | $1,069 | 4 | $0 (2019) |
| PFIZER INC. | $972.17 | 50 | $0 (2024) |
| Braintree Laboratories, Inc. | $472.40 | 29 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $437.20 | 19 | $0 (2024) |
| Allergan Inc. | $364.92 | 37 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $349.58 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,446 | 164 | ABBVIE INC. ($926.03) |
| 2023 | $2,540 | 127 | ABBVIE INC. ($758.06) |
| 2022 | $2,574 | 127 | ABBVIE INC. ($1,015) |
| 2021 | $2,140 | 117 | Janssen Biotech, Inc. ($708.95) |
| 2020 | $669.23 | 44 | AbbVie Inc. ($291.40) |
| 2019 | $2,821 | 122 | Covidien LP ($1,058) |
| 2018 | $2,014 | 116 | AbbVie, Inc. ($470.01) |
| 2017 | $1,115 | 81 | Valeant Pharmaceuticals North America LLC ($284.20) |
All Payment Transactions
898 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Immunology | ||||||
| 12/11/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Gastroenterology | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.80 | General |
| 11/14/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: Immunology | ||||||
| 11/12/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $32.60 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/12/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.65 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $32.74 | General |
| Category: LIVER DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 555 | 612 | $213,644 | $58,844 |
| 2022 | 13 | 602 | 651 | $253,874 | $64,870 |
| 2021 | 13 | 581 | 656 | $208,196 | $60,155 |
| 2020 | 13 | 577 | 694 | $183,966 | $51,033 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 62 | 62 | $48,732 | $12,694 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 137 | 165 | $19,305 | $10,165 | 52.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 47 | 47 | $29,610 | $8,263 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 91 | $15,106 | $7,773 | 51.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 78 | 81 | $39,285 | $5,271 | 13.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 41 | 42 | $29,148 | $4,698 | 16.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $7,515 | $3,400 | 45.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 18 | $11,340 | $2,203 | 19.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,198 | $1,631 | 51.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 12 | 15 | $7,125 | $1,407 | 19.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 16 | 16 | $1,920 | $676.92 | 35.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 17 | $1,360 | $660.90 | 48.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 70 | 71 | $55,806 | $13,445 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 141 | $23,406 | $13,101 | 56.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 46 | 46 | $28,980 | $8,024 | 27.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 100 | 103 | $49,955 | $6,056 | 12.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 105 | $12,285 | $5,937 | 48.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 45 | 45 | $31,230 | $4,674 | 15.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $15,750 | $3,492 | 22.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 17 | 17 | $10,710 | $3,033 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $5,904 | $2,345 | 39.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $5,177 | $2,162 | 41.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 14 | 15 | $7,125 | $1,265 | 17.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $5,746 | $853.99 | 14.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 15 | 15 | $1,800 | $482.16 | 26.8% |
About Dr. Thomas Lee, MD
Dr. Thomas Lee, MD is a Gastroenterology healthcare provider based in Camillus, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1568652261.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Lee, MD has received a total of $17,318 in payments from pharmaceutical and medical device companies, with $3,446 received in 2024. These payments were reported across 898 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($16,040).
As a Medicare-enrolled provider, Lee has provided services to 2,315 Medicare beneficiaries, totaling 2,613 services with total Medicare billing of $234,902. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Camillus, NY
- Active Since 07/28/2007
- Last Updated 04/27/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1568652261
Products in Payments
- STELARA (Biological) $1,644
- RINVOQ (Biological) $1,391
- XIFAXAN (Drug) $1,389
- XELJANZ (Drug) $921.25
- SKYRIZI (Biological) $873.13
- HUMIRA (Biological) $732.08
- ENTYVIO (Biological) $681.95
- Humira (Biological) $471.16
- OCALIVA (Drug) $437.20
- DUPIXENT (Biological) $399.06
- LINZESS (Drug) $395.64
- Entyvio (Biological) $345.17
- TREMFYA (Drug) $307.40
- Cimzia (Drug) $299.72
- ZEPOSIA (Drug) $287.75
- XIFIXAN (Drug) $282.93
- DIFICID (Drug) $276.78
- Linzess (Drug) $248.00
- VIBERZI (Drug) $203.45
- SUPREP BOWEL PREP (Drug) $201.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Camillus
Dr. John Sun, Do, DO
Gastroenterology — Payments: $18,336
Scott Edison, Md, MD
Gastroenterology — Payments: $18,054
Theodore Koh, Md, MD
Gastroenterology — Payments: $11,945
Christine Granato, M.d, M.D
Gastroenterology — Payments: $7,714
Margaret Spinosa, Md, MD
Gastroenterology — Payments: $3,176
James Tifft, Md, MD
Gastroenterology — Payments: $962.77